NewsNew UK Cannabis Fund Closes In On Its First...

New UK Cannabis Fund Closes In On Its First $75m Investment

-

ONE of the UK’s first cannabis investment funds is being backed by two of the industry’s global leaders as it closes in on its first $75m investment.

News of the launch of the Verdite Capital Fund emerged last month and it officially opened its doors, today.

Formed by London-based entrepreneurial corporate finance and investment house Chrystal Capital Partners LLP it is looking to raise $100m by the end of the year.

Bruce Linton In As Advisor

In a press release announcing its launch Chrystal says it has formed a football-size team of 11 sector experts, which includes Bruce Linton, the founder of Canopy Growth and Colin Stott, former R&D Director of GW Pharmaceuticals.

Bruce Linton, Cannabis Executive

It also says its first close of US$100m is planned for the end of 2020, with US$75m committed from a cornerstone investor. 

Investment partner Kingsley Wilson said: “We are delighted to launch Verdite, a fund that will address the equity funding gap in the hugely exciting and growing medicinal cannabis market. 

“Overseen by a team with decades of cannabis and private equity experience, we believe that Verdite presents the vehicle through which investors can profit from the significant value creation that is now unfolding globally across the legal cannabis healthcare space.” 

Looking For Up To 15 Investees

The Verdite private equity fund is targeting investments in ‘well-managed, fast-growing companies active in legal and regulated cannabis and cannabinoid markets around the world, with a focus on the medical, pharmaceutical and wellness sectors’. 

Verdite says it initial aim is to create a diversified portfolio of 10-15 investments in these markets, adding the Fund will not invest in the recreational market. 

Reflecting on the growth of the industry and its future prospects it highlights the total estimated size of the cannabis market at $350bn a year, of which just $15bn is currently legal and regulated. 

Cannabis – A Once in A Lifetime Opportunity

Adding: “An industry of this size coming out of prohibition is a once in a lifetime investment opportunity. Over the next decade the market will transition into a legal market, where it can be regulated, monitored, taxed and most importantly for investors, profited from.”

Chrystal made its first cannabis investment four years ago and has now deployed over $210m into the sector on behalf of investors. 

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

3 COMMENTS

  1. Thank you so much,am also looking for some people who can come and invest in the same business in Uganda please

  2. That’s great news. I wish that other countries will follow this practice. UK really developed when it comes to cannabis in an extremely short period of time.

Comments are closed.

Latest news

European Cannabis Stocks Review: Love Hemp Announces ‘Cessation’ Of LSE Listing Process, More From Cellular Goods & Stenocare

Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May...

European Round-Up: Successful Cannabis Debut For Chemical Multinational, Germany Addresses Hurdles To Reform, French Medical Cannabis Twist, Maltese Hold-Ups et al…

CONCERNS the creation of an adult-use cannabis market will contravene international law have been dismissed by senior members of...

Glass Pharms Announces Partners In UK Cultivation Facility: KUBO To Build State-Of-The-Art Greenhouse 

HAVING secured up to £26.7m of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis...

Newly-Approved European Hemp Seeds To Deliver Record Levels Of CBD

BULGARIAN firm CBD Seed Europe has secured a place on the European seed register for two of its genetics...

Drug Coordinators From 27 EU Member States Meet In Prague To Discuss Cannabis Legalisation As Czechia Moves Closer To Recreational Market

EARLIER this month representatives from all 27 EU member states, alongside non-governmental experts, NGO’s and private sector representatives, came...

European Cannabis Stocks Review: Akanda Signs With Cookies, IM Cannabis Sees Slight Recovery, & Futura Medical Prepares For FDA Approval

Markets across Europe opened lower this morning as ongoing and increasingly severe reports of a looming economic crisis pushed...

Must read

You might also likeRELATED
Recommended to you